# Etomidate

NDC: 67457-902
Generic name: Etomidate
Labeler / Manufacturer: Mylan Institutional LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20190301

FDA application: ANDA201044

## Active ingredients

- ETOMIDATE: 2 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"67457-902"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=67457-902
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=461e34d1-b862-4a02-9727-548c907aac48